ConductScience.org, home

Paper7244243

Hepatic artery embolization in the treatment of hepatic neoplasms.

Chuang VP and 1 other. Radiology, 1981. Cited by 294 papers, by iCite.

Cite this record

ConductScience Library. Hepatic artery embolization in the treatment of hepatic neoplasms. Papers, record 7244243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7244243

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hepatic artery embolization in the treatment of hepatic neoplasms.
PubMed
Journal
Radiology
PubMed
Year
1981
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
294
iCite
Relative citation ratio, by iCite
12.7
iCite
Revised in PubMed
2004-11-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chuang VPV P
2Wallace SS

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Embolization, TherapeuticMajor topic
Liver NeoplasmsMajor topic
Adult
Alkaline Phosphatase
Aspartate Aminotransferases
Fever
Hepatic Artery
Humans
L-Lactate Dehydrogenase
Male
Middle Aged
Pain

Source PubMed

Download CSV of topics

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 294 citations.

PMIDTitleJournalYearIn PapersSource
39656891A Lipiodol Pickering Emulsion Stabilized by Iron-Doped Carbon Nanozymes for Liver Transarterial Chemoembolization.Adv Sci (Weinh)2025https://conductscience.org/library/papers/39656891PubMed
39587611Efficacy of arterial compression hemostasis devices in liver cancer treatment: a systematic review and meta-analysis.World J Surg Oncol2024https://conductscience.org/library/papers/39587611PubMed
32679897Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies.Cancers (Basel)2020https://conductscience.org/library/papers/32679897PubMed
31768343Locoregional Therapy, Immunotherapy and the Combination in Hepatocellular Carcinoma: Future Directions.Liver Cancer2019https://conductscience.org/library/papers/31768343PubMed
30274202Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection.Viruses2018https://conductscience.org/library/papers/30274202PubMed
29866075Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial.BMC Cancer2018https://conductscience.org/library/papers/29866075PubMed
28975829Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.Cancer Control2017https://conductscience.org/library/papers/28975829PubMed
26167344Inferior Phrenic Arteries and Their Branches, Their Anatomy and Possible Clinical Importance: An Experimental Cadaver Study.Balkan Med J2015https://conductscience.org/library/papers/26167344PubMed
25984668Hepatic angiosarcoma may have fair survival nowadays.Medicine (Baltimore)2015https://conductscience.org/library/papers/25984668PubMed
24073316What Is the Most Effective Drug Delivery System for Cisplatin during the Treatment of Hepatic Tumors with Single-Session Transcatheter Chemotherapy? A Pilot Study.Gut Liver2013https://conductscience.org/library/papers/24073316PubMed
19718288A comparative study of intratumoral chemotherapy in advanced childhood common solid tumors.Indian J Urol2007https://conductscience.org/library/papers/19718288PubMed
18749412Radiology-important advances in clinical medicine: vascular occlusive therapy.West J Med1983https://conductscience.org/library/papers/18749412PubMed
18560973Living donor liver transplantation in a patient with giant hepatic hemangioma complicated by Kasabach-Merritt syndrome: report of a case.Surg Today2008https://conductscience.org/library/papers/18560973PubMed
18046645Chemo-embolization for unresectable hepatocellular carcinoma with different sizes of embolization particles.Dig Dis Sci2008https://conductscience.org/library/papers/18046645PubMed
12482130Vasoactive intestinal polypeptide-secreting tumor (VIPoma) with liver metastases: dramatic and durable symptomatic benefit from hepatic artery embolization, a case report.Med Oncol2002https://conductscience.org/library/papers/12482130PubMed
9250900Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer--a pilot study.J Gastroenterol1997https://conductscience.org/library/papers/9250900PubMed
9213258Transcatheter arterial embolization-induced bilious pleuritis in a patient with hepatocellular carcinoma.J Gastroenterol1997https://conductscience.org/library/papers/9213258PubMed
8591620Malignant insulinoma: permanent hepatic artery embolization of liver metastases--preliminary results.Cardiovasc Intervent Radiol1995https://conductscience.org/library/papers/8591620PubMed
8533187Hepatic abscess formation following embolisation of a carcinoid metastasis.Ulster Med J1995https://conductscience.org/library/papers/8533187PubMed
8383379Extension of surgical indications for hepatocellular carcinoma by portal vein embolization.World J Surg1993https://conductscience.org/library/papers/8383379PubMed

See all 58 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7244243

GET https://conductscience.org/api/papers/v1/7244243/cited_by?page=2